For the year ending 2025-12-31, LBRX has $312,934K in assets. $11,624K in debts. $250,173K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 250,173 | |||
| Marketable securities | 45,040 | |||
| Prepaid expenses and other current assets | 13,219 | |||
| Total current assets | 308,432 | |||
| Operating lease right-of-use assets, net | 2,151 | |||
| Property and equipment | 2,001 | |||
| Less accumulated depreciation | 420 | |||
| Property and equipment, net | 1,581 | |||
| Restricted cash | 770 | |||
| Total assets | 312,934 | |||
| Accounts payable | 2,127 | |||
| Accrued expenses | 4,585 | |||
| Operating lease liability, current | 730 | |||
| Total current liabilities | 7,442 | |||
| Derivative liability - warrants | 1,343 | |||
| Operating lease liability, noncurrent | 2,839 | |||
| Total liabilities | 11,624 | |||
| Preferred stock , value-Series Seed Preferred Stock | 0 | |||
| Preferred stock , value-Series APreferred Stock | 0 | |||
| Preferred stock , value-Series BPreferred Stock | 0 | |||
| Preferred stock , value-Series CPreferred Stock | 0 | |||
| Common stock, 0.0001 par value, 500,000,000 and 105,000,000 shares authorized, 25,299,372 and 251,655 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 3 | |||
| Additional paid-in capital | 430,667 | |||
| Accumulated deficit | -129,528 | |||
| Accumulated other comprehensive income | 168 | |||
| Total stockholders' equity (deficit) | 301,310 | |||
| Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) | 312,934 | |||
LB PHARMACEUTICALS INC (LBRX)
LB PHARMACEUTICALS INC (LBRX)